nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—PDE3A—cGMP effects—PDE5A—primary biliary cirrhosis	0.00736	0.273	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—PDE5A—primary biliary cirrhosis	0.00585	0.217	CbGpPWpGaD
Anagrelide—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00313	CcSEcCtD
Anagrelide—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00302	0.00311	CcSEcCtD
Anagrelide—Dehydration—Colchicine—primary biliary cirrhosis	0.003	0.00309	CcSEcCtD
Anagrelide—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00307	CcSEcCtD
Anagrelide—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00298	0.00307	CcSEcCtD
Anagrelide—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00305	CcSEcCtD
Anagrelide—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00305	CcSEcCtD
Anagrelide—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00304	CcSEcCtD
Anagrelide—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00296	0.00304	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00298	CcSEcCtD
Anagrelide—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00298	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00298	CcSEcCtD
Anagrelide—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00298	CcSEcCtD
Anagrelide—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00293	CcSEcCtD
Anagrelide—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.00285	0.00293	CcSEcCtD
Anagrelide—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00279	CcSEcCtD
Anagrelide—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00279	CcSEcCtD
Anagrelide—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.0027	0.00277	CcSEcCtD
Anagrelide—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.0027	0.00277	CcSEcCtD
Anagrelide—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00275	CcSEcCtD
Anagrelide—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00275	CcSEcCtD
Anagrelide—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00267	0.00275	CcSEcCtD
Anagrelide—Pancytopenia—Colchicine—primary biliary cirrhosis	0.00265	0.00272	CcSEcCtD
Anagrelide—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00272	CcSEcCtD
Anagrelide—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00272	CcSEcCtD
Anagrelide—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00264	CcSEcCtD
Anagrelide—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00264	CcSEcCtD
Anagrelide—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00258	CcSEcCtD
Anagrelide—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00253	CcSEcCtD
Anagrelide—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00246	0.00253	CcSEcCtD
Anagrelide—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00251	CcSEcCtD
Anagrelide—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00244	0.00251	CcSEcCtD
Anagrelide—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00248	CcSEcCtD
Anagrelide—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00248	CcSEcCtD
Anagrelide—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00247	CcSEcCtD
Anagrelide—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00247	CcSEcCtD
Anagrelide—Haematuria—Colchicine—primary biliary cirrhosis	0.00237	0.00244	CcSEcCtD
Anagrelide—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00241	CcSEcCtD
Anagrelide—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00241	CcSEcCtD
Anagrelide—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00238	CcSEcCtD
Anagrelide—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00238	CcSEcCtD
Anagrelide—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00235	CcSEcCtD
Anagrelide—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00235	CcSEcCtD
Anagrelide—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00234	CcSEcCtD
Anagrelide—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00234	CcSEcCtD
Anagrelide—PDE3A—Platelet homeostasis—PDE5A—primary biliary cirrhosis	0.00228	0.0844	CbGpPWpGaD
Anagrelide—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00233	CcSEcCtD
Anagrelide—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00233	CcSEcCtD
Anagrelide—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00231	CcSEcCtD
Anagrelide—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.00231	CcSEcCtD
Anagrelide—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00229	CcSEcCtD
Anagrelide—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00229	CcSEcCtD
Anagrelide—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00222	0.00228	CcSEcCtD
Anagrelide—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00226	CcSEcCtD
Anagrelide—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00226	CcSEcCtD
Anagrelide—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00226	CcSEcCtD
Anagrelide—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00226	CcSEcCtD
Anagrelide—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00225	CcSEcCtD
Anagrelide—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00225	CcSEcCtD
Anagrelide—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00223	CcSEcCtD
Anagrelide—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00223	CcSEcCtD
Anagrelide—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00223	CcSEcCtD
Anagrelide—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00223	CcSEcCtD
Anagrelide—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00214	0.0022	CcSEcCtD
Anagrelide—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00214	0.0022	CcSEcCtD
Anagrelide—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00219	CcSEcCtD
Anagrelide—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00219	CcSEcCtD
Anagrelide—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00217	CcSEcCtD
Anagrelide—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00217	CcSEcCtD
Anagrelide—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00217	CcSEcCtD
Anagrelide—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00211	0.00217	CcSEcCtD
Anagrelide—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00216	CcSEcCtD
Anagrelide—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00216	CcSEcCtD
Anagrelide—Eye disorder—Colchicine—primary biliary cirrhosis	0.00209	0.00214	CcSEcCtD
Anagrelide—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00207	CcSEcCtD
Anagrelide—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00207	CcSEcCtD
Anagrelide—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00201	0.00207	CcSEcCtD
Anagrelide—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00207	CcSEcCtD
Anagrelide—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00207	CcSEcCtD
Anagrelide—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00206	CcSEcCtD
Anagrelide—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.00206	CcSEcCtD
Anagrelide—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00205	CcSEcCtD
Anagrelide—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00205	CcSEcCtD
Anagrelide—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00204	CcSEcCtD
Anagrelide—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00204	CcSEcCtD
Anagrelide—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00203	CcSEcCtD
Anagrelide—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00203	CcSEcCtD
Anagrelide—Alopecia—Colchicine—primary biliary cirrhosis	0.00197	0.00203	CcSEcCtD
Anagrelide—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00203	CcSEcCtD
Anagrelide—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00203	CcSEcCtD
Anagrelide—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00202	CcSEcCtD
Anagrelide—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00202	CcSEcCtD
Anagrelide—Malnutrition—Colchicine—primary biliary cirrhosis	0.00194	0.002	CcSEcCtD
Anagrelide—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00199	CcSEcCtD
Anagrelide—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00193	0.00199	CcSEcCtD
Anagrelide—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00193	CcSEcCtD
Anagrelide—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00193	CcSEcCtD
Anagrelide—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00192	CcSEcCtD
Anagrelide—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00192	CcSEcCtD
Anagrelide—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00187	0.00192	CcSEcCtD
Anagrelide—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00191	CcSEcCtD
Anagrelide—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00191	CcSEcCtD
Anagrelide—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00186	CcSEcCtD
Anagrelide—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00186	CcSEcCtD
Anagrelide—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00185	CcSEcCtD
Anagrelide—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00185	CcSEcCtD
Anagrelide—Anaemia—Colchicine—primary biliary cirrhosis	0.0018	0.00185	CcSEcCtD
Anagrelide—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00184	CcSEcCtD
Anagrelide—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00184	CcSEcCtD
Anagrelide—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00182	CcSEcCtD
Anagrelide—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00182	CcSEcCtD
Anagrelide—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.0018	CcSEcCtD
Anagrelide—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.0018	CcSEcCtD
Anagrelide—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00177	CcSEcCtD
Anagrelide—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00177	CcSEcCtD
Anagrelide—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00176	CcSEcCtD
Anagrelide—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00176	CcSEcCtD
Anagrelide—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00174	CcSEcCtD
Anagrelide—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00174	CcSEcCtD
Anagrelide—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00174	CcSEcCtD
Anagrelide—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00174	CcSEcCtD
Anagrelide—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00173	CcSEcCtD
Anagrelide—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00173	CcSEcCtD
Anagrelide—Arthralgia—Colchicine—primary biliary cirrhosis	0.00166	0.0017	CcSEcCtD
Anagrelide—Myalgia—Colchicine—primary biliary cirrhosis	0.00166	0.0017	CcSEcCtD
Anagrelide—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00167	CcSEcCtD
Anagrelide—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00167	CcSEcCtD
Anagrelide—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00166	CcSEcCtD
Anagrelide—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00166	CcSEcCtD
Anagrelide—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00162	CcSEcCtD
Anagrelide—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00162	CcSEcCtD
Anagrelide—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00161	CcSEcCtD
Anagrelide—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00161	CcSEcCtD
Anagrelide—Shock—Colchicine—primary biliary cirrhosis	0.00156	0.0016	CcSEcCtD
Anagrelide—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00156	0.0016	CcSEcCtD
Anagrelide—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00155	0.0016	CcSEcCtD
Anagrelide—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00159	CcSEcCtD
Anagrelide—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00159	CcSEcCtD
Anagrelide—Skin disorder—Colchicine—primary biliary cirrhosis	0.00154	0.00158	CcSEcCtD
Anagrelide—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00158	CcSEcCtD
Anagrelide—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00158	CcSEcCtD
Anagrelide—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00157	CcSEcCtD
Anagrelide—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00157	CcSEcCtD
Anagrelide—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00156	CcSEcCtD
Anagrelide—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00156	CcSEcCtD
Anagrelide—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00155	CcSEcCtD
Anagrelide—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00155	CcSEcCtD
Anagrelide—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00153	CcSEcCtD
Anagrelide—Hypotension—Colchicine—primary biliary cirrhosis	0.00148	0.00152	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00152	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00152	CcSEcCtD
Anagrelide—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00151	CcSEcCtD
Anagrelide—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.00151	CcSEcCtD
Anagrelide—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00149	CcSEcCtD
Anagrelide—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00149	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00145	0.00149	CcSEcCtD
Anagrelide—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00148	CcSEcCtD
Anagrelide—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00148	CcSEcCtD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—primary biliary cirrhosis	0.00143	0.0529	CbGpPWpGaD
Anagrelide—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00147	CcSEcCtD
Anagrelide—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00147	CcSEcCtD
Anagrelide—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00146	CcSEcCtD
Anagrelide—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00146	CcSEcCtD
Anagrelide—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00144	CcSEcCtD
Anagrelide—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00144	CcSEcCtD
Anagrelide—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00144	CcSEcCtD
Anagrelide—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00144	CcSEcCtD
Anagrelide—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00143	CcSEcCtD
Anagrelide—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00143	CcSEcCtD
Anagrelide—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00143	CcSEcCtD
Anagrelide—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00143	CcSEcCtD
Anagrelide—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00142	CcSEcCtD
Anagrelide—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00142	CcSEcCtD
Anagrelide—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00138	0.00142	CcSEcCtD
Anagrelide—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00142	CcSEcCtD
Anagrelide—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00138	0.00142	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00137	0.00141	CcSEcCtD
Anagrelide—Fatigue—Colchicine—primary biliary cirrhosis	0.00137	0.00141	CcSEcCtD
Anagrelide—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0014	CcSEcCtD
Anagrelide—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0014	CcSEcCtD
Anagrelide—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00137	CcSEcCtD
Anagrelide—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00137	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00133	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.0013	0.00133	CcSEcCtD
Anagrelide—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.0013	0.00133	CcSEcCtD
Anagrelide—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00133	CcSEcCtD
Anagrelide—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00133	CcSEcCtD
Anagrelide—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00132	CcSEcCtD
Anagrelide—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00132	CcSEcCtD
Anagrelide—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00131	CcSEcCtD
Anagrelide—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00131	CcSEcCtD
Anagrelide—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.0013	CcSEcCtD
Anagrelide—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.0013	CcSEcCtD
Anagrelide—Urticaria—Colchicine—primary biliary cirrhosis	0.00126	0.0013	CcSEcCtD
Anagrelide—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00129	CcSEcCtD
Anagrelide—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00129	CcSEcCtD
Anagrelide—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00125	0.00129	CcSEcCtD
Anagrelide—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00127	CcSEcCtD
Anagrelide—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00127	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00126	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00126	CcSEcCtD
Anagrelide—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00126	CcSEcCtD
Anagrelide—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00126	CcSEcCtD
Anagrelide—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00125	CcSEcCtD
Anagrelide—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00125	CcSEcCtD
Anagrelide—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00125	CcSEcCtD
Anagrelide—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00125	CcSEcCtD
Anagrelide—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00121	CcSEcCtD
Anagrelide—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00121	CcSEcCtD
Anagrelide—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.0012	CcSEcCtD
Anagrelide—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.0012	CcSEcCtD
Anagrelide—Asthenia—Colchicine—primary biliary cirrhosis	0.00114	0.00117	CcSEcCtD
Anagrelide—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00116	CcSEcCtD
Anagrelide—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00109	0.00112	CcSEcCtD
Anagrelide—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00105	CcSEcCtD
Anagrelide—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00105	CcSEcCtD
Anagrelide—Vomiting—Colchicine—primary biliary cirrhosis	0.00101	0.00104	CcSEcCtD
Anagrelide—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00104	CcSEcCtD
Anagrelide—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00104	CcSEcCtD
Anagrelide—Rash—Colchicine—primary biliary cirrhosis	0.001	0.00103	CcSEcCtD
Anagrelide—Dermatitis—Colchicine—primary biliary cirrhosis	0.000999	0.00103	CcSEcCtD
Anagrelide—Headache—Colchicine—primary biliary cirrhosis	0.000994	0.00102	CcSEcCtD
Anagrelide—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000975	0.001	CcSEcCtD
Anagrelide—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000975	0.001	CcSEcCtD
Anagrelide—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000943	0.000969	CcSEcCtD
Anagrelide—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000943	0.000969	CcSEcCtD
Anagrelide—Nausea—Colchicine—primary biliary cirrhosis	0.000942	0.000969	CcSEcCtD
Anagrelide—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000906	0.000931	CcSEcCtD
Anagrelide—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000906	0.000931	CcSEcCtD
Anagrelide—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000899	0.000924	CcSEcCtD
Anagrelide—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000899	0.000924	CcSEcCtD
Anagrelide—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.000923	CcSEcCtD
Anagrelide—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.000923	CcSEcCtD
Anagrelide—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000893	0.000918	CcSEcCtD
Anagrelide—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000893	0.000918	CcSEcCtD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000858	0.0318	CbGpPWpGaD
Anagrelide—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000847	0.00087	CcSEcCtD
Anagrelide—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000847	0.00087	CcSEcCtD
Anagrelide—CYP1A2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000804	0.0298	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000564	0.0209	CbGpPWpGaD
Anagrelide—CYP1A2—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.00056	0.0208	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—NOS2—primary biliary cirrhosis	0.000556	0.0206	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—RAD51B—primary biliary cirrhosis	0.000549	0.0203	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PDE5A—primary biliary cirrhosis	0.00051	0.0189	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.000497	0.0184	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000422	0.0157	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000312	0.0116	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000258	0.00958	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000253	0.00938	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00023	0.00851	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00023	0.00851	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000209	0.00773	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000164	0.00609	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000161	0.00598	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000149	0.00551	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000141	0.00523	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000136	0.00503	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS2—primary biliary cirrhosis	0.000124	0.00461	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000123	0.00457	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.00012	0.00443	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000114	0.00423	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000112	0.00414	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000109	0.00403	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ALB—primary biliary cirrhosis	0.000105	0.00388	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000103	0.00382	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—MMP3—primary biliary cirrhosis	9.91e-05	0.00367	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	9.62e-05	0.00356	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCL5—primary biliary cirrhosis	9.35e-05	0.00347	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	9.01e-05	0.00334	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AGT—primary biliary cirrhosis	8.62e-05	0.00319	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AGT—primary biliary cirrhosis	7.82e-05	0.0029	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	6.62e-05	0.00245	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.42e-05	0.00238	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MMP3—primary biliary cirrhosis	5.85e-05	0.00217	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.85e-05	0.00217	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCL5—primary biliary cirrhosis	5.52e-05	0.00205	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.35e-05	0.00198	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	4.79e-05	0.00177	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.64e-05	0.00172	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AGT—primary biliary cirrhosis	4.62e-05	0.00171	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.32e-05	0.0016	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	4.27e-05	0.00158	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CD80—primary biliary cirrhosis	4.09e-05	0.00152	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	4.01e-05	0.00149	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	4.01e-05	0.00149	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.69e-05	0.00137	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TYK2—primary biliary cirrhosis	3.46e-05	0.00128	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.29e-05	0.00122	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MMP9—primary biliary cirrhosis	2.72e-05	0.00101	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.69e-05	0.000998	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.56e-05	0.000949	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	2.41e-05	0.000893	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	2.24e-05	0.000831	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.96e-05	0.000728	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	1.92e-05	0.000713	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	1.91e-05	0.000706	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	1.64e-05	0.00061	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	1.64e-05	0.00061	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.46e-05	0.000543	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.14e-05	0.000423	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	8.75e-06	0.000324	CbGpPWpGaD
